Test Bank For Maternity, Newborn, and Women's Health Nursing: A Case-Based Approach
First Edition
by Dr. Amy O'Meara
All Chapters | Expert Verified Answers | Grade A+
1|Page
, TESTBANKS BY TESTSBANKSNERD
TABLE OF CONTENTS
Chapter 1 Immediate Postpartum Hemorrhage
Chapter 2 Later Postpartum Hemorrhage
Chapter 3 Gestational Diabetes, Deep Vein Thrombosis, and Postpartum Pulmonary Embolism
Chapter 4 Preeclampsia
Chapter 5 Cord Prolapse and Nonreassuring Fetal Status
Chapter 6 Placental Abruption and Fetal Loss
Chapter 7 Chorioamnionitis and Neonatal Sepsis
Chapter 8 Preterm Premature Rupture of Membranes and Neonatal Respiratory Distress Syndrome
Chapter 9 Gestational Diabetes, Macrosomia, and Neonatal Cephalhematoma
Chapter 10 Advanced Maternal Age, HELLP Syndrome, and Neonatal Necrotizing Enterocolitis
Chapter 11 Migraine With Aura, Shoulder Dystocia, and Brachial Plexus Palsy
Chapter 12 Intimate Partner Violence, Formula Feeding, and Postpartum Depression
Chapter 13 Gestational Trophoblastic Disease (Molar Pregnancy) and Advanced Maternal Age
Chapter 14 Before Conception
Chapter 15 Pregnancy
Chapter 16 Labor and Delivery
Chapter 17 After Delivery
Chapter 18 The Newborn
Chapter 19 Conditions Existing Before Conception
Chapter 20 Conditions Occurring During Pregnancy
Chapter 21 Complications Occurring Before Labor and Delivery
Chapter 22 Complications Occurring During Labor and Delivery Chapter 23 Conditions Occurring
After Delivery
Chapter 24 Conditions in the Newborn Related to Gestational Age, Size, Injury, and Pain
Chapter 25 Acquired Conditions and Congenital Abnormalities in the Newborn
Chapter 26 Wellness and Health Promotion Chapter 27 Common Gynecologic Conditions
Chapter 28 Infections
Chapter 29 Family Planning
Chapter 30 Vulnerable Populations
2|Page
, TESTBANKS BY TESTSBANKSNERD
Chapter 1 Immediate Postpartum Hemorrhage
MULTIPLE CHOICE
1. A pregnant woman is being discharged from the hospital after the placement of a cervical
cerclage because of a history of recurrent pregnancy loss, secondary to an incompetent cervix.
Which information regarding postprocedural care should the nurse emphasize in the discharge
teaching?
a. Any vaginal discharge should be immediately reported to her health care provider.
b. The presence of any contractions, rupture of membranes (ROM), or severe perineal
pressure sho
c. The client will need to make arrangements for care at home, because her activity level will
be re
d. The client will be scheduled for a cesarean birth.
ANSWER: B
Nursing care should stress the importance of monitoring for the signs and symptoms of preterm
labor. Vaginal bleeding needs to be reported to her primary health care provider. Bed rest is an
element of care. However, the woman may stand for periods of up to 90 minutes, which allows her
the freedom to see her physician. Home uterine activity monitoring may be used to limit the
womans need for visits and to monitor her status safely at home. The cerclage can be removed at37
weeks of gestation (to prepare for a vaginal birth), or a cesarean birth can be planned.
DIF: Cognitive Level: Apply REF: dm. 675
TOP: Nursing Process: Planning | Nursing Process: ImplementationMSC:
Client Needs: Health Promotion and Maintenance
2. A perinatal nurse is giving discharge instructions to a woman, status postsuction, and
curettage secondary to a hydatidiform mole. The woman asks why she must take oral
contraceptives for the next 12 months. What is the bestresponse by the nurse?
If you get pregnant within 1 year, the chance of a successful pregnancy is very small. Therefore,
a. pregnancy, it would be better for you to use the most reliable method of contraception
available.
The major risk to you after a molar pregnancy is a type of cancer that can be diagnosed only
byhormone that your body produces during pregnancy. If you were to get pregnant, then it would
b. this cancer more difficult.
If you can avoid a pregnancy for the next year, the chance of developing a second molar pregna
c. improve your chance of a successful pregnancy, not getting pregnant at this time is best.
d. Oral contraceptives are the only form of birth control that will prevent a recurrence of a
molar
3|Page
, TESTBANKS BY TESTSBANKSNERD
ANSWER: B
Betahuman chorionic gonadotropin (beta-hCG) hormone levels are drawn for 1 year to ensure
that the mole is completely gone. The chance of developing choriocarcinoma after the development
of a hydatidiform mole is increased. Therefore, the goal is to achieve a zero humanchorionic
gonadotropin (hCG) level. If the woman were to become pregnant, then it may obscurethe presence
of the potentially carcinogenic cells. Women should be instructed to use birth control for 1 year
after treatment for a hydatidiform mole. The rationale for avoiding pregnancy
for 1 year is to ensure that carcinogenic cells are not present. Any contraceptive method exceptan
intrauterine device (IUD) is acceptable.
DIF: Cognitive Level: Apply REF: dm. 679
TOP: Nursing Process: Planning | Nursing Process: ImplementationMSC: Client Needs: Physiologic
Integrity
3. The nurse is preparing to administer methotrexate to the client. This hazardous drug is
most often used for which obstetric complication?
a. Complete hydatidiform mole
b. Missed abortion
c. Unruptured ectopic pregnancy
d. Abruption placentae
ANSWER: C
Methotrexate is an effective nonsurgical treatment option for a hemodynamically stable woman
whose ectopic pregnancy is unruptured and measures less than 4 cm in diameter. Methotrexate
isnot indicated or recommended as a treatment option for a complete hydatidiform mole, for a
missed abortion, or for abruptio placentae.
DIF: Cognitive Level: Apply REF: dm. 677 TOP: Nursing Process: PlanningMSC: Client Needs:
Physiologic Integrity
4. A 26-year-old pregnant woman, gravida 2, para 1-0-0-1, is 28 weeks pregnant when she
experiences bright red, painless vaginal bleeding. On her arrival at the hospital, which diagnostic
procedure will the client most likely have performed?
a. Amniocentesis for fetal lung maturity
b. Transvaginal ultrasound for placental location
c. Contraction stress test (CST)
d. Internal fetal monitoring
4|Page